Retrospective survey of malignant lymphoma cases in the dog: Clinical, therapeutical and prognostic features

Veterinary Research Communications

Volumn 32, Issue SUPPL. 1, 2008, Pages

  Gavazza, A ^a,b   Lubas, G ^a   Valori, E ^a   Gugliucci, B ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Department of Veterinary Clinic ^*  (Italy)

Author keywords

Chemotherapy; Clinical features; Dog; Lymphoma; Prognostic factors

Indexed keywords

CORTICOSTEROID;

ANAMNESIS; CONFERENCE PAPER; CONTROLLED STUDY; DOG; FEMALE; FOLLOW UP; LABORATORY TEST; LYMPHOMA; MALE; NONHUMAN; PHYSICAL EXAMINATION; PROGNOSIS; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SURVIVAL TIME;

ANEMIA; ANIMALS; DOG DISEASES; DOGS; FEMALE; LEUKEMIA; LYMPHOMA; MALE; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; THROMBOCYTOPENIA;

CANIS FAMILIARIS;

EID: 52049088344     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-008-9131-1     Document Type: Conference Paper

References (6)

1. Baskin C.R., Couto C.G., Wittum T.E., 2000. Factors influencing first remission and survival in 145 dogs with lymphoma: A retrospective study. Journal of the American Hospital Association, 36, 404-409.
2. Dhaliwal R.S., Kitchell B.E., Messick J.B., 2004. Il linfosarcoma nel cane: Caratteristiche cliniche. Veterinaria, 18(2), 39-47.
3. Dorn C.R., Taylor D.O., Schneider R., 1970. The epidemiology of canine leukemia and lymphoma. Bibliotheca Hematologica, 36, 403-415.
4. Frimberger A.E., 2002. New protocols for canine lymphoma. Conference Proceedings: Tufts Animal Expo, North Grafton, MA, USA.
5. Jain N.C., 1993. Schalm's Veterinary Hematology. Lea & Febiger: Philadelphia.
6. Price G.S., Page R.L., Fischer B.M., Levine J.F., Gerig T.M., 1991. Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma. Journal of Veterinary Internal Medicine, 5, 259-262.